CXCL8 and cancer: Clinical studies have shown that IL-8 levels in serum and plasma typically range from 10 to 100 ng/mL in patients with advanced cancers, such as breast, lung, and colon carcinoma, whereas early-stage or low-grade tumors may exhibit IL-8 concentrations in the sub-ng/mL to low-ng/mL range.